Anna Zalewska

5.6k total citations
216 papers, 4.3k citations indexed

About

Anna Zalewska is a scholar working on Physiology, Molecular Biology and Periodontics. According to data from OpenAlex, Anna Zalewska has authored 216 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Physiology, 47 papers in Molecular Biology and 41 papers in Periodontics. Recurrent topics in Anna Zalewska's work include Salivary Gland Disorders and Functions (68 papers), Oral microbiology and periodontitis research (38 papers) and Biochemical effects in animals (37 papers). Anna Zalewska is often cited by papers focused on Salivary Gland Disorders and Functions (68 papers), Oral microbiology and periodontitis research (38 papers) and Biochemical effects in animals (37 papers). Anna Zalewska collaborates with scholars based in Poland, United Kingdom and Philippines. Anna Zalewska's co-authors include Mateusz Maciejczyk, Napoleon Waszkiewicz, Krzysztof Zwierz, Małgorzata Żendzian‐Piotrowska, Małgorzata Knaś, Jerzy Robert Ładny, Danuta Waszkiel, Anna Klimiuk, Adrian Chabowski and Julita Szulimowska and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Anna Zalewska

205 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Zalewska Poland 38 1.9k 946 850 448 411 216 4.3k
Mateusz Maciejczyk Poland 37 1.5k 0.8× 851 0.9× 656 0.8× 437 1.0× 386 0.9× 166 3.7k
Mohammad Taghi Goodarzi Iran 33 610 0.3× 889 0.9× 289 0.3× 272 0.6× 350 0.9× 189 3.1k
Antonio Hernández‐Mijares Spain 38 1.1k 0.6× 1.4k 1.5× 238 0.3× 291 0.6× 772 1.9× 183 4.9k
Mario D. Cordero Spain 43 783 0.4× 2.8k 3.0× 225 0.3× 202 0.5× 695 1.7× 109 5.5k
Milagros Rocha Spain 43 1.5k 0.8× 2.3k 2.4× 119 0.1× 432 1.0× 1.1k 2.6× 146 6.2k
Christina Piperi Greece 51 979 0.5× 2.8k 3.0× 126 0.1× 1.1k 2.5× 699 1.7× 257 8.4k
Süleyman Aydın Türkiye 38 2.4k 1.3× 1.4k 1.5× 94 0.1× 158 0.4× 963 2.3× 260 5.8k
Celia Bañuls Spain 31 788 0.4× 1.3k 1.4× 86 0.1× 244 0.5× 482 1.2× 102 3.4k
Marcelo N. Muscará Brazil 36 1.3k 0.7× 1.0k 1.1× 232 0.3× 51 0.1× 176 0.4× 190 4.7k
João Tiago Guimarães Portugal 35 801 0.4× 831 0.9× 75 0.1× 218 0.5× 453 1.1× 206 3.9k

Countries citing papers authored by Anna Zalewska

Since Specialization
Citations

This map shows the geographic impact of Anna Zalewska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Zalewska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Zalewska more than expected).

Fields of papers citing papers by Anna Zalewska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Zalewska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Zalewska. The network helps show where Anna Zalewska may publish in the future.

Co-authorship network of co-authors of Anna Zalewska

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Zalewska. A scholar is included among the top collaborators of Anna Zalewska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Zalewska. Anna Zalewska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Żendzian‐Piotrowska, Małgorzata, et al.. (2025). Inhibition of protein glycation by vasodilatory β-blockers – In vitro studies and in silico analyses. Biomedicine & Pharmacotherapy. 185. 117976–117976. 1 indexed citations
2.
Żendzian‐Piotrowska, Małgorzata, et al.. (2025). A comparative study on the antioxidant and antiglycation properties of different vitamin D forms. European Journal of Medicinal Chemistry. 285. 117263–117263. 4 indexed citations
3.
Rekiel, A., et al.. (2025). Pig Welfare and Productivity in Selected Alternative Systems. A Niche Market for Pork. Annals of Animal Science. 26(1). 147–156.
4.
Błachnio‐Zabielska, Agnieszka, Mateusz Maciejczyk, Jan Borys, et al.. (2025). Profile of the Main Representatives of Sphingolipid Metabolism in the Maxillary and Mandibular Periosteum of Patients with Dentofacial Deformities After Osteosynthesis Using Titanium Implants. Journal of Clinical Medicine. 14(6). 1929–1929. 1 indexed citations
7.
Zalewska, Anna, et al.. (2025). Salivary Biomarkers for the Diagnosis of Sjögren’s Syndrome: A Review of the Last Decade. Biomedicines. 13(11). 2664–2664.
8.
Zalewska, Anna, et al.. (2025). Can Salivary Biomarkers Serve as Diagnostic and Prognostic Tools for Early Detection in Patients with Colorectal Cancer? A Systematic Review. Current Issues in Molecular Biology. 47(8). 647–647. 2 indexed citations
9.
Dorf, Justyna, et al.. (2024). The antiglycation potential of H1 receptor antagonists – in vitro studies in bovine serum albumin model and in silico molecular docking analyses. Biomedicine & Pharmacotherapy. 175. 116632–116632. 6 indexed citations
10.
Żendzian‐Piotrowska, Małgorzata, et al.. (2024). Novel Properties of Old Propranolol─Assessment of Antiglycation Activity through In Vitro and In Silico Approaches. ACS Omega. 9(25). 27559–27577. 5 indexed citations
13.
Szara, Ewa, et al.. (2023). Quantitative and Qualitative Traits of Duckweed (Lemna minor) Produced on Growth Media with Pig Slurry. Agronomy. 13(7). 1951–1951. 9 indexed citations
14.
Zalewska, Anna, et al.. (2023). A Review of Preclinical and Clinical Studies in Support of the Role of Non-Steroidal Anti-Inflammatory Drugs in Dentistry. Medical Science Monitor. 29. e940635–e940635. 10 indexed citations
15.
Więdłocha, Magdalena, Piotr Marcinowicz, Weronika Dębowska, et al.. (2023). Oxidative Stress Biomarkers among Schizophrenia Inpatients. Brain Sciences. 13(3). 490–490. 27 indexed citations
16.
Maciejczyk, Mateusz, Iwona Ptaszyńska-Sarosiek, Anna Niemcunowicz‐Janica, et al.. (2022). Do Circulating Redox Biomarkers Have Diagnostic Significance in Alcohol-Intoxicated People?. International Journal of Molecular Sciences. 23(19). 11808–11808. 7 indexed citations
18.
Zalewska, Anna, et al.. (2022). Enzymatic antioxidants activity in gingival crevicular fluid and saliva in advanced periodontitis. Oral Diseases. 29(8). 3559–3570. 8 indexed citations
19.
Żendzian‐Piotrowska, Małgorzata, et al.. (2021). Pleiotropic Properties of Valsartan: Do They Result from the Antiglycooxidant Activity? Literature Review and In Vitro Study. Oxidative Medicine and Cellular Longevity. 2021(1). 5575545–5575545. 17 indexed citations
20.
Zalewska, Anna, et al.. (2013). Nonspecific Immune Factors in the Whole Unstimulated Saliva of Human Infants, Children and Adolescents. Dental and Medical Problems. 50(3). 291–297. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026